Gu SL - Search Results

1

Silencing aquaporin 1 inhibits autophagy to exert anti-rheumatoid arthritis effects in TNF-α-induced fibroblast-like synoviocytes and adjuvant-induced arthritis rats : Names of authors.

Zhang MY, Wang MQ, Huang Y, Gu SL, Zhou MY, Xu ZS, Li LL, Lv M, Cai L, Li R. Zhang MY, et al. Among authors: gu sl. Inflamm Res. 2025 Jan 8;74(1):12. doi: 10.1007/s00011-024-01966-6. Inflamm Res. 2025. PMID: 39774992

2

Mitochondrial genomes of four slug moths (Lepidoptera, Limacodidae): Genome description and phylogenetic implications.

Jiang F, Yu XD, Sun ET, Gu SL, Liu Y, Liu T. Jiang F, et al. Among authors: gu sl. Ecol Evol. 2024 Apr 29;14(5):e11319. doi: 10.1002/ece3.11319. eCollection 2024 May. Ecol Evol. 2024. PMID: 38694746 Free PMC article.

3

CPD-002, a novel VEGFR2 inhibitor, relieves rheumatoid arthritis by reducing angiogenesis through the suppression of the VEGFR2/PI3K/AKT signaling pathway.

Jiang F, Wang MQ, Zhang MY, Gu SL, Xie YW, Huang Y, Zhou MY, Li FL, Yang YC, Zhang PP, Liu XS, Li R. Jiang F, et al. Among authors: gu sl. Int Immunopharmacol. 2024 Apr 20;131:111850. doi: 10.1016/j.intimp.2024.111850. Epub 2024 Mar 12. Int Immunopharmacol. 2024. PMID: 38479157

4

Shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy via modulation of the AMPK/mTOR/ULK-1 signaling pathway.

Wang XH, Shen CP, Wang TT, Huang Y, Jin Y, Zhou MY, Zhang MY, Gu SL, Wang MQ, Liu ZC, Li R, Cai L. Wang XH, et al. Among authors: gu sl. Phytomedicine. 2024 Jun;128:155512. doi: 10.1016/j.phymed.2024.155512. Epub 2024 Mar 2. Phytomedicine. 2024. PMID: 38460357

5

Post-crotonylation oxidation by a monooxygenase promotes acetyl-CoA synthetase degradation in Streptomyces roseosporus.

Ma BB, Sun CF, Zhou JY, Gu SL, Dai XY, Chen YZ, Zhao QW, Mao XM. Ma BB, et al. Among authors: gu sl. Commun Biol. 2023 Dec 8;6(1):1243. doi: 10.1038/s42003-023-05633-0. Commun Biol. 2023. PMID: 38066175 Free PMC article.

6

Safety of Immunomodulatory Systemic Therapies Used in the Management of Immune-Related Cutaneous Adverse Events.

Gu SL, Nath S, Markova A. Gu SL, et al. Pharmaceuticals (Basel). 2023 Nov 15;16(11):1610. doi: 10.3390/ph16111610. Pharmaceuticals (Basel). 2023. PMID: 38004475 Free PMC article. Review.

7

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events.

Gu SL, Maier T, Moy AP, Dusza S, Faleck DM, Shah NJ, Lacouture ME. Gu SL, et al. Pharmaceuticals (Basel). 2023 Nov 2;16(11):1548. doi: 10.3390/ph16111548. Pharmaceuticals (Basel). 2023. PMID: 38004414 Free PMC article.

8

Dermatologic complications in transplantation and cellular therapy for acute leukemia.

Babakoohi S, Gu SL, Ehsan H, Markova A. Babakoohi S, et al. Among authors: gu sl. Best Pract Res Clin Haematol. 2023 Jun;36(2):101464. doi: 10.1016/j.beha.2023.101464. Epub 2023 Apr 6. Best Pract Res Clin Haematol. 2023. PMID: 37353285 Free PMC article. Review.

9

Clinical characteristics of patients with prenatal hydronephrosis in early postnatal period: a single center retrospective study.

Gu SL, Yang XQ, Zhai YH, Xu WL, Guo WX, Shen T. Gu SL, et al. BMC Pediatr. 2023 May 12;23(1):235. doi: 10.1186/s12887-023-04063-5. BMC Pediatr. 2023. PMID: 37173710 Free PMC article.

10

A Nomogram for Predicting Physical Restraint of Patients in Intensive Care Unit.

Wang Y, Liu Y, Tian YL, Gu SL. Wang Y, et al. Among authors: gu sl. Emerg Med Int. 2023 Apr 17;2023:6618366. doi: 10.1155/2023/6618366. eCollection 2023. Emerg Med Int. 2023. PMID: 37101766 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters